Navigation Links
Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT
Date:12/6/2019

Southern California medical device manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein thrombosis (DVT) treatment. The company’s early clinical data suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical removal of soft emboli and thrombi without the need for aspiration, thrombolytics, or capital equipment.

“We are very pleased to receive FDA 510(k) clearance for our latest CAPERE® thrombectomy catheter that significantly expands the treatment options for physicians. We have also received our ninth U.S. patent on the technology and are excited about the potential of CAPERE® to improve patient outcomes and reduce costs for the healthcare system,” Vascular Medcure CEO, Samuel Shaolian said.

Mr. Shaolian further stated, “The CAPERE® Thrombectomy System does not use thrombolytics which may be a significant time saver in busy care facilities. With no capital equipment required, the CAPERE® Thrombectomy System is a cost effective, low-profile, 8Fr, over-the-wire approach, that provides interventional radiologists and interventional cardiologists on the table results, when treating these challenging patients.”

The CAPERE® Thrombectomy System, which utilizes its patented, dynamic basket technology, was developed to provide a mechanical thrombectomy approach for fast and effective treatment of patients with deep vein thrombosis and to provide on the table results. CAPERE® is designed to offers significant improvement over existing products by not requiring the use of aspiration – whereby minimizing blood loss, thrombolytics, or expensive capital equipment.

For more information, visit http://www.vascularmedcure.com

Contact:

David Mills, Vice President of Sales & Marketing
David@vascularmedcure.com

Read the full story at https://www.prweb.com/releases/vascular_medcure_receives_third_fda_clearance_for_capere_thrombectomy_system_a_mechanical_device_for_treatment_of_dvt/prweb16766589.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. uBiome Awards Grant to North Carolina A&T State University to Study Gut Microbiome and Cardiovascular Health Risks in African-American Athletes
2. New Stago Webinar Offers Insight on Coagulation Testing for Disseminated Intravascular Coagulation
3. Dr. Daniel Spyker, Former FDA acting Deputy Division Director of Cardiovascular, Respiratory, and Neurological Devices, Joins NDA Partners
4. Dr. Steven Brooks, Former FDA Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation, Joins NDA Partners
5. Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease
6. Renova Therapeutics secures novel AAV vector license for use in metabolic and cardiovascular gene therapy development
7. Cardiovascular Medical Devices: World Market, Industry, Trends and Revenue Forecasts 2015-2025
8. CardioCell Board Members and Clinical Trial Leads Collaborate on Peer-Reviewed Paper Published in the Journal of Cardiovascular Medicine
9. Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD
10. QT Vascular Announces The Allowance Of Four New Patents
11. Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 11, 2020 , ... Modality ... for free its new white paper – Simulated Transport Methodologies. Regulatory expectations ... biologics licensing application (BLA). In response, Modality Solutions shares an explanation of ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health ... growth, , Known as MediVet Biologics since its formation in ... The new Ardent Animal Health will build on its base of innovative therapies ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced new ... for use with CRM, neurostimulation, vascular, and related devices. , Anomet Medical ... requirements, performance, and cost criteria; especially where solid wire is limited. Typical configurations ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... software for the life sciences industry, today announced the release of its ... specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
Breaking Biology Technology:
(Date:8/7/2020)... ... August 06, 2020 , ... ... pleased to announce that Eric Chen and Jessica Wong have joined the company’s ... & Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today ... by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the ... and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
Breaking Biology News(10 mins):